Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Artelo Biosciences Inc (ARTL)

Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Artelo Biosciences Inc 505 LOMAS SANTA FE SUITE 160 SOLANA BEACH CA 92075 USA

www.artelobio.com Employees: 6 P: 858-925-7049

Description:

Artelo Biosciences Inc. is a biopharmaceutical company. It is engaged in development and commercialization of proprietary therapeutics targeting the endocannabinoid system. The company's product pipeline consists of ART27.13, ART12.11 and ART26.12 which are in clinical stage. Artelo Biosciences Inc. is based in La Jolla, CA.

Key Statistics

Overview:

Market Capitalization, $K 3,131
Enterprise Value, $K 311
Shares Outstanding, K 3,228
Annual Sales, $ 0 K
Annual Net Income, $ -9,290 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,130 K
EBIT, $ -9,540 K
EBITDA, $ -9,540 K
60-Month Beta 1.29
% of Insider Shareholders 0.83%
% of Institutional Shareholders 0.87%
Float, K 3,201
% Float 99.17%
Short Volume Ratio 0.40

Growth:

1-Year Return -28.15%
3-Year Return -87.54%
5-Year Return -97.52%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 8.99%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.35 on 11/12/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -2.87
EPS Growth vs. Prev Qtr 53.33%
EPS Growth vs. Prev Year 57.83%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 08/10/22

ARTL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -104.59%
Return-on-Assets % -94.06%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.49
Book Value/Share 1.97
Interest Coverage -1.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar